Josep Gomez Lara
Latest contributions
A journey into the ANOCA and INOCA dilemma
21 May 2025 – From EuroPCR 2025
Explore the complex clinical dilemma of ANOCA and INOCA with focus on angina endotypes, prognostic stratification, metabolic phenotype associations, and microvascular function assessment using indices such as microcirculatory resistance and microvascular resistance reserve.
Imaging-guided management of PCI pitfalls in NSTEMI
21 May 2025 – From EuroPCR 2025
Dive into the imaging-guided management of PCI pitfalls in NSTEMI patients. This session highlights critical cases such as complications from missed PCI, crushed stents, multiple coronary lumens, and migrating thrombus, emphasizing the role of advanced intracoronary imaging for precise diagnosis and optimized interventional outcomes.
Role of imaging in ACS: from non-invasive to invasive investigations
20 May 2025 – From EuroPCR 2025
Explore the critical role of imaging in acute coronary syndrome (ACS) from non-invasive coronary CT angiography to invasive intracoronary imaging modalities. This session covers detection of culprit lesions, diagnostic strategies, and PCI optimization through real-world case examples.
Complex coronary artery disease: how to use intracoronary imaging in daily practice challenges?
16 May 2024 – From EuroPCR 2024
This session, in collaboration with various cardiology societies, focuses on the use of intracoronary imaging to optimize percutaneous coronary intervention (PCI) in complex coronary artery disease. It presents case studies demonstrating the role of imaging-based assessment of coronary calcified lesions, the importance of a standardized imaging...
Vulnerable plaque identification and treatment
16 May 2024 – From EuroPCR 2024
This session focuses on the role of non-invasive and intra-coronary imaging in the identification and management of vulnerable plaque. Participants will explore the use of CCTA and intracoronary imaging techniques, such as IVUS, to diagnose vulnerable atherosclerosis. The session also evaluates the evidence supporting conservative or...
PCR e-Course Hot lines: drugs and devices for STEMI management
Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.
